Archive | Psychiatric drugs

james-davies2 200x262

Major milestone: Royal College releases new guidance on stopping antidepressants

Today I welcome the new patient information leaflet, entitled ‘Stopping Antidepressants’, published by the Royal College of Psychiatrists.  The leaflet distills many years of work by researchers, campaigners and the prescribed harm community, which has jointly challenged previous understandings of antidepressant withdrawal as being a relatively benign experience for most people.  Instead, the leaflet now […]

Continue Reading 39

Guest blog: Call for an independent review into the practice of ECT

By Lucy Johnstone and Sue Cunliffe Electroconvulsive therapy, or ECT, is still given to about 2,100 -2,700 people a year in England, about half of whom have not consented to it. This blog reports on a campaign for an independent review of this highly controversial procedure, and provides links to relevant articles. There will be […]

Continue Reading 4

Blog: Are our regulatory bodies prioritising drug company interests over public safety?

The Disturbing Case of the Street Drug Ketamine The UK’s Medicines & Healthcare Products Regulatory Agency (MHRA) is refusing to respond to the concerns of psychiatrists, parliamentarians, patients and other experts about the impending licensing of the street drug ketamine as a treatment for depression. In March this year, the USA’s Food and Drug Administration […]

Continue Reading 13

BBC is looking for people willing to appear in documentary on antidepressant withdrawal

The BBC is producing a documentary about the long-term side effects and withdrawal effects of antidepressant medication. They are looking to speak to individuals who have decided to come off their medication and would be open to allowing us to follow their journey throughout this process, alongside the reporter of the film who will be […]

Continue Reading 68

CEP welcomes trailblazing report by Public Health England on withdrawal and dependence on psychoactive drugs

CEP today welcomes the publication of a report by Public Health England which recognises for the first time the scale of prescribing of drugs that can cause dependence and withdrawal.  The report shows that one in four adults in England has been prescribed a benzodiazepine, z-drug, gabapentinoid, opioid or antidepressant in the past twelve months, with up to […]

Continue Reading 21
Michael_nah_1500x1928

Hengartner and Plöderl respond to Hayes et al’s commentary on their article on suicide risk with antidepressants

In our recent study published in the journal Psychotherapy and Psychosomatics, we showed that adults who start antidepressants for depression are 2.5 times more likely to attempt suicide when compared to those starting placebo. This equates to 1 in every 200 people attempting suicide as a direct effect of taking the antidepressant. This number is […]

Continue Reading 7
Screenshot 2019-08-23 at 08.53.38

Guest blog: Are you coming to the drug lunch?

This is the question raised at least every 2 months in our NHS psychosis team. Most of us will go without a second thought (I have to admit, I usually do. There are free M&S sandwiches, fruit, biscuits and pastries; “That’s all the moral compass I need”, I like to joke). We have the usual […]

Continue Reading 6

New study: antidepressants significantly raise the risk of suicide in the treatment of depression for adults

Adults who start treatment with antidepressants for depression are 2.5 times more likely to attempt suicide when compared to placebo, according to new research published today in the journal Psychotherapy and Psychosomatics. The study found that approximately 1 in every 200 people who start treatment will attempt suicide due to the pharmacologic effects of the […]

Continue Reading 29

Campaigning persuades Royal College of Psychiatrists to change its position on antidepressant withdrawal

Following campaigning by CEP, the All Party Parliamentary Group for Prescribed Drug Dependence and numerous members of the #prescribedharm community, the Royal College of Psychiatrists has today changed its position on antidepressant withdrawal.  It has issued a revised policy statement updating its guidance to doctors, and calls upon NICE to update its guidelines as well. […]

Continue Reading 37

Don’t blame Brexit: doubling of antidepressant prescriptions in fact reflects longer-term use

The news that 70.9 million antidepressant prescriptions were dispensed in England last year – almost double the figure in 2008 – is an admission of failure. Some medical and mental health organisations have speculated that this rise reflects increased awareness of mental health problems and greater willingness to seek help, and others have even blamed […]

Continue Reading 22

Powered by WordPress. Designed by WooThemes